137 related articles for article (PubMed ID: 29891609)
1. Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.
Gonzalez D; James LP; Al-Uzri A; Bosheva M; Adler-Shohet FC; Mendley SR; Bradley JS; Espinosa C; Tsonkova E; Moffett K; Marquez L; Simonsen KA; Stoilov S; Boakye-Agyeman F; Jasion T; Hornik CP; Hernandez R; Benjamin DK; Cohen-Wolkowiez M
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891609
[TBL] [Abstract][Full Text] [Related]
2. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
Oldach D; Clark K; Schranz J; Das A; Craft JC; Scott D; Jamieson BD; Fernandes P
Antimicrob Agents Chemother; 2013 Jun; 57(6):2526-34. PubMed ID: 23507282
[TBL] [Abstract][Full Text] [Related]
4. Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment.
Jamieson BD; Ciric S; Fernandes P
Antimicrob Agents Chemother; 2015 Aug; 59(8):4379-86. PubMed ID: 25870056
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
Barrera CM; Mykietiuk A; Metev H; Nitu MF; Karimjee N; Doreski PA; Mitha I; Tanaseanu CM; Molina JM; Antonovsky Y; Van Rensburg DJ; Rowe BH; Flores-Figueroa J; Rewerska B; Clark K; Keedy K; Sheets A; Scott D; Horwith G; Das AF; Jamieson B; Fernandes P; Oldach D;
Lancet Infect Dis; 2016 Apr; 16(4):421-30. PubMed ID: 26852726
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
Still JG; Schranz J; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ; Clark K
Antimicrob Agents Chemother; 2011 May; 55(5):1997-2003. PubMed ID: 21282444
[TBL] [Abstract][Full Text] [Related]
7. Solithromycin: A novel ketolide antibiotic.
Buege MJ; Brown JE; Aitken SL
Am J Health Syst Pharm; 2017 Jun; 74(12):875-887. PubMed ID: 28432048
[TBL] [Abstract][Full Text] [Related]
8. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
Salerno SN; Carreño FO; Edginton AN; Cohen-Wolkowiez M; Gonzalez D
Drug Metab Dispos; 2021 Sep; 49(9):844-855. PubMed ID: 34154994
[TBL] [Abstract][Full Text] [Related]
9. Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: A meta-analysis of randomised controlled trials.
Wen J; Chen F; Zhao M; Wang X
Int J Clin Pract; 2019 May; 73(5):e13333. PubMed ID: 30810253
[TBL] [Abstract][Full Text] [Related]
10. A Dried Blood Spot Analysis for Solithromycin in Adolescents, Children, and Infants: A Short Communication.
Beechinor RJ; Cohen-Wolkowiez M; Jasion T; Hornik CP; Lang JE; Hernandez R; Gonzalez D
Ther Drug Monit; 2019 Dec; 41(6):761-765. PubMed ID: 31318840
[TBL] [Abstract][Full Text] [Related]
11. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
[TBL] [Abstract][Full Text] [Related]
12. Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia.
Lang JE; Hornik CP; Elliott C; Silverstein A; Hornik C; Al-Uzri A; Bosheva M; Bradley JS; Borja-Tabora CFC; Di John D; Mendez Echevarria A; Ericson JE; Friedel D; Gonczi F; Isidro MGD; James LP; Kalocsai K; Koutroulis I; Laki I; Ong-Lim ALT; Nad M; Simon G; Syed S; Szabo E; Benjamin DK; Cohen-Wolkowiez M;
Pediatr Infect Dis J; 2022 Jul; 41(7):556-562. PubMed ID: 35675525
[TBL] [Abstract][Full Text] [Related]
13. Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
Salerno SN; Edginton A; Cohen-Wolkowiez M; Hornik CP; Watt KM; Jamieson BD; Gonzalez D
CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):814-822. PubMed ID: 29068158
[TBL] [Abstract][Full Text] [Related]
14. A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
Arrieta AC; Sung L; Bradley JS; Zwaan CM; Gates D; Waskin H; Carmelitano P; Groll AH; Lehrnbecher T; Mangin E; Joshi A; Kartsonis NA; Walsh TJ; Paschke A
PLoS One; 2019; 14(3):e0212837. PubMed ID: 30913226
[TBL] [Abstract][Full Text] [Related]
15. Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.
Gonzalez D; Palazzi DL; Bhattacharya-Mithal L; Al-Uzri A; James LP; Bradley J; Neu N; Jasion T; Hornik CP; Smith PB; Benjamin DK; Keedy K; Fernandes P; Cohen-Wolkowiez M
Antimicrob Agents Chemother; 2016 Apr; 60(4):2572-6. PubMed ID: 26883693
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, Excretion, and Mass Balance of Solithromycin in Humans.
MacLauchlin C; Schneider SE; Keedy K; Fernandes P; Jamieson BD
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507061
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin.
Evans D; Yalkowsky S; Wu S; Pereira D; Fernandes P
J Pharm Sci; 2018 Jan; 107(1):412-418. PubMed ID: 29107789
[TBL] [Abstract][Full Text] [Related]
18. A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea.
Hook EW; Golden M; Jamieson BD; Dixon PB; Harbison HS; Lowens S; Fernandes P
Clin Infect Dis; 2015 Oct; 61(7):1043-8. PubMed ID: 26089222
[TBL] [Abstract][Full Text] [Related]
19. Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.
Keelan JA; Kemp MW; Payne MS; Johnson D; Stock SJ; Saito M; Fernandes P; Newnham JP
Antimicrob Agents Chemother; 2014; 58(1):447-54. PubMed ID: 24189250
[TBL] [Abstract][Full Text] [Related]
20. The role of solithromycin in the management of bacterial community-acquired pneumonia.
Van Bambeke F; Tulkens PM
Expert Rev Anti Infect Ther; 2016; 14(3):311-24. PubMed ID: 26848612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
